Alpha 2.0
Login Register
» Authors » Joaquina Mauricio

Joaquina Mauricio

Explore the profile of Joaquina Mauricio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 445
Followers 0
Related Specialties
Oncology
General Medicine
Molecular Biology
Top 10 Co-Authors
Rui Medeiros
Rui Henrique
Joao Lobo
Carmen Jeronimo
Francisca Dias
Isaac Braga
Rita Guimaraes
Mariana Cantante
Marta Ferreira
Francisco Lobo
Published In
PLoS One
Andrology
Cancers (Basel)
DNA Cell Biol
Tumour Biol
Affiliations
Soon will be listed here.
Recent Articles
1.
Differential expression of metabolic enzymes in testicular germ cell tumors: The impact of glycolytic metabolism in embryonal carcinoma histotype
Cantante M, Miranda-Goncalves V, Tavares N, Guimaraes R, Braga I, Mauricio J, et al.
Andrology . 2024 Dec; PMID: 39711015
Background: Testicular germ cell tumors are the most common solid malignancies in young men, with increasing incidence worldwide. Broadly classified into seminomas and non-seminomas, they exhibit distinct biological behaviors and...
2.
Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review
Rodrigues P, Faustino C, Mauricio J, Carneiro F
Cureus . 2024 Jul; 16(6):e63506. PMID: 39081434
Metastatic prostate cancer treatment is based on androgen deprivation, with pharmacological or surgical castration. This treatment may be complemented with the addition of antiandrogenic drugs. In the setting of prostate-specific...
3.
EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors
Estevao-Pereira H, Guimaraes-Teixeira C, Flores B, Moreira-Silva F, Tavares N, Guimaraes R, et al.
Andrology . 2024 Feb; 13(2):286-295. PMID: 38380739
Background: Testicular germ cell tumors remain the most frequent solid malignancies in young males. Despite excellent prognosis, the fact that only 60% of patients at diagnosis have elevated serum tumor...
4.
DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients
Sequeira J, Lobo J, Constancio V, Brito-Rocha T, Carvalho-Maia C, Braga I, et al.
Front Oncol . 2022 Jun; 12:876732. PMID: 35756620
Testicular germ cell tumors (TGCTs) are the most common cancers in young-adult male patients aged between 15 and 39 years. Hsa-miR-371a-3p is currently the most reliable biomarker for diagnosis and...
5.
Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm
Lourenco B, Guimaraes-Teixeira C, Flores B, Miranda-Goncalves V, Guimaraes R, Cantante M, et al.
Life (Basel) . 2022 Feb; 12(2). PMID: 35207551
TGCTs represent a model of curable disease afflicting especially young men. Defining tumor biological characteristics is crucial to increase current knowledge and tailor the best clinical management. Ki67, a potential...
6.
expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes
Teixeira A, Patrao A, Dias F, Silva C, Vieira I, Silva J, et al.
Pharmacogenomics . 2021 Oct; 22(16):1069-1079. PMID: 34672687
Renal cell carcinoma (RCC) is the most lethal urological cancer and up to 40% of patients submitted to surgery will relapse. Thus, the study aim was to analyze the associations...
7.
The component of the mA writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors
Miranda-Goncalves V, Lobo J, Guimaraes-Teixeira C, Barros-Silva D, Guimaraes R, Cantante M, et al.
J Exp Clin Cancer Res . 2021 Aug; 40(1):268. PMID: 34446080
Background: Germ cell tumors (GCTs) are developmental cancers, tightly linked to embryogenesis and germ cell development. The recent and expanding field of RNA modifications is being increasingly implicated in such...
8.
Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples
Lobo J, Constancio V, Leite-Silva P, Guimaraes R, Cantante M, Braga I, et al.
Clin Epigenetics . 2021 Apr; 13(1):70. PMID: 33823933
Testicular germ cell tumors (TGCTs) are among the most common solid malignancies in young-adult men, and currently most mortality is due to metastatic disease and emergence of resistance to cisplatin....
9.
Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors
Lobo J, Constancio V, Guimaraes-Teixeira C, Leite-Silva P, Miranda-Goncalves V, Sequeira J, et al.
Mol Oncol . 2021 Jan; 15(4):846-865. PMID: 33513287
Testicular germ cell tumors (TGCTs) are the most common cancers in men aged 15-39 years and are divided into two major groups, seminomas and nonseminomas. Novel treatment options are required...
10.
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
Lobo J, Guimaraes-Teixeira C, Barros-Silva D, Miranda-Goncalves V, Camilo V, Guimaraes R, et al.
Cancers (Basel) . 2020 Oct; 12(10). PMID: 33050470
Novel treatment options are needed for testicular germ cell tumor (TGCT) patients, particularly important for those showing or developing cisplatin resistance, the major cause of cancer-related deaths. As TGCTs pathobiology...